|
|
Post by Clement on Jan 1, 2019 10:17:02 GMT -5
|
|
|
|
Post by Clement on Jan 1, 2019 11:19:17 GMT -5
Press release: United Therapeutics Corporation To Present At 37th Annual J.P. Morgan Healthcare Conference SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Dec. 31, 2018 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive Officer of United Therapeutics, will provide an overview and update on the company's business at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco, California. The presentation and the immediately following Q&A session will take place on Monday, January 7, 2019, at 2:30 PM Pacific Standard Time, and can be accessed via a live webcast on the United Therapeutics website at www.unither.com under the "Investors" tab in the "Events and Presentations" section. An archived, recorded version of the presentation and the Q&A session will be available approximately twenty-four hours after the Q&A session ends and can be accessed at the same location for 90 days. [uthr-g] |
|
|
|
Post by letitride on Jan 1, 2019 20:24:59 GMT -5
Thanks for the heads up.
|
|
|
|
Post by ezrasfund on Jan 2, 2019 21:00:29 GMT -5
Now I'm having PTSD flashbacks to those Sanofi conference calls where they didn't even mention Afrezza.
|
|
|
|
Post by wsulylecoug on Jan 7, 2019 12:51:26 GMT -5
"We’re going to be very busy hosting investor and business development meetings around the JPMorgan Healthcare Conference next week in San Francisco. And because we are presenting, we thought it was prudent to update investors on our 2019 strategic imperatives."
I can't seem to find when MNKD will be presenting at JPM. The JPM website says "The agenda is made available only to confirmed attendees" and MNKD website doesn't have it listed. Are they presenting or not?
|
|
|
|
Post by mannmade on Jan 7, 2019 12:55:21 GMT -5
My understanding is they are there to present in private meetings like they did last year. Not to publically present.
|
|
|
|
Post by Clement on Jan 7, 2019 14:33:26 GMT -5
UTHR 5:30 PM EST
|
|
|
|
Post by mannmade on Jan 7, 2019 14:35:06 GMT -5
Maybe we will get a significant mention from uthr as part of their future. Would be nice!
|
|
|
|
Post by centralcoastinvestor on Jan 7, 2019 17:32:42 GMT -5
Anyone listening in on this? Would love to hear whether MannKind is mentioned.
|
|
|
|
Post by tingtongtung on Jan 7, 2019 17:39:25 GMT -5
Anyone listening in on this? Would love to hear whether MannKind is mentioned. Just saw the slides. MNKD is on 3/4 slides. No time to listen. |
|
|
|
Post by harryx1 on Jan 7, 2019 17:40:16 GMT -5
|
|
|
|
Post by Omega on Jan 7, 2019 17:48:00 GMT -5
"Technosphere is being developed to replace the Tyvaso Nebulizer" was the only thing I caught in time to start typing.   |
|
|
|
Post by wsulylecoug on Jan 7, 2019 17:50:19 GMT -5
Anyone listening in on this? Would love to hear whether MannKind is mentioned. Just saw the slides. MNKD is on 3/4 slides. No time to listen. Listening now...pay particular attention to what is said during slide 10. There's a good future ahead for Technosphere with UTHR, growing populations that could benefit from it with P3 trails going now scheduled to end in 2020. Exciting stuff! |
|
|
|
Post by itellthefuture777 on Jan 7, 2019 19:29:48 GMT -5
"Technosphere is being developed to replace the Tyvaso Nebulizer" was the only thing I caught in time to start typing. ..Nebulizer out..Technosphere in..for their #2 most paying drug...that alone should wake up some folks.. |
|
|
|
Post by wsulylecoug on Jan 7, 2019 19:32:59 GMT -5
"Technosphere is being developed to replace the Tyvaso Nebulizer" was the only thing I caught in time to start typing. ..Nebulizer out..Technosphere in..for their #2 most paying drug...that alone should wake up some folks.. To also be used for the INCREASE and PERFECT populations as well with successful P3 results, neither of which currently have FDA approved treatments...WHO Groups 1 and 3. Scheduled to read out in 2020 and 2021. |
|
